RegNav, an AI-powered compliance management platform, and Tricardia, a leading MedTech start-up consultancy, are working together to help MedTech start-ups obtain regulatory compliance for their new medical innovations.
Often a highly complex and time-consuming milestone to achieve, regulatory compliance can account for a significant proportion of the cost of launching and maintaining medical technology products in the marketplace.
Through this new partnership, Tricardia’s portfolio of MedTech startup clients and investors will be able to draw on RegNav’s expertise in the regulatory space, and gain access to its AI-powered ‘human in the loop’ product compliance lifecycle platform.
Natalie Seatter, Head of RegNav said: “It’s vital that medical device start-ups and their investors understand the complex regulatory pathway at an early stage, including likely costs and timelines, so they can factor this into their business plans and go-to-market strategies. It is often the most challenging milestone to complete when launching a new product and we believe our mentorship and AI-powered compliance platform will be indispensable.”
Neil Douglas, CEO of Tricardia added: “We are really pleased to announce this partnership with RegNav. Regulation is a common challenge for many of our start-up customers and they will greatly benefit from the mentoring and expertise of RegNav to understand what’s required and how they can get to market in a timely, cost-effective and efficient manner in order to have the greatest impact on patient outcomes.”
